Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 9 December 2008, doi:10.1136/bmj.a2930
Cite this as: BMJ 2008;337:a2930
Annette Tuffs, freelance journalist
1 Heidelberg
atuffs@web.de
Annette Tuffs talks to Nobel prize winner, Harald zur Hausen, about his career
| The first 150 words of the full text of this article appear below. |
Harald zur Hausens small office is on the bottom floor of a three storey building that might well be named after him in the future, but now is called Applied Tumour Virology and belongs to the German Cancer Research Centre next door.
At 72, zur Hausen, one of the three Nobel prize laureates in medicine 2008, comes here almost every day, whenever his commitments as a much sought after speaker at meetings allow. Although he retired as chairman of the cancer research centre in May 2003, he remains active in research, especially in the search for viruses. He tells me that viruses are responsible for about 20% of all malignant tumours and so need to be explored much further "The most likely candidates for viral aetiology are lymphoma and leukaemia," he says, pointing out that new viruses and subtypes are detected every year.
The Nobel prize did not come as
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?